A UPLC/MS-based metabolomics investigation of the protective effect of ginsenosides Rg1 and Rg2 in mice with Alzheimer's disease

BACKGROUND: Alzheimer's disease (AD) is a progressive brain disease, for which there is no effective drug therapy at present. Ginsenoside Rg1 (G-Rg1) and G-Rg2 have been reported to alleviate memory deterioration. However, the mechanism of their anti-AD effect has not yet been clearly elucidate...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Naijing, Liu, Ying, Li, Wei, Zhou, Ling, Li, Qing, Wang, Xueqing, He, Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4703800/
https://www.ncbi.nlm.nih.gov/pubmed/26843817
http://dx.doi.org/10.1016/j.jgr.2015.04.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4703800/
https://www.ncbi.nlm.nih.gov/pubmed/26843817
http://dx.doi.org/10.1016/j.jgr.2015.04.006

Ejemplares similares